Wellington Management Group
ARTV

Wellington Management Group’s Artiva Biotherapeutics ARTV Stock Holding History

Wellington Management Group’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Hold
194,108
– – ﹤0.01% 1641
2026
Q1 		$1.25M Hold
194,108
– – ﹤0.01% 1636
2025
Q4 		$833K Hold
194,108
– – ﹤0.01% 1749
2025
Q3 		$557K Hold
194,108
– – ﹤0.01% 1871
2025
Q2 		$293K Hold
194,108
– – ﹤0.01% 1881
2025
Q1 		$582K Hold
194,108
– – ﹤0.01% 1802
2024
Q4 		$1.95M Hold
194,108
– – ﹤0.01% 1570
2024
Q3 		$2.91M Buy
+194,108
New +$2.25M ﹤0.01% 1453

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Wellington Management Group's ARTV Position: Q2 2026 in Review

Wellington Management Group held its Artiva Biotherapeutics (ARTV) position steady in Q2 2026 at 194,108 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1641.

Wellington Management Group first reported a position in ARTV in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.91M in Q3 2024. 72 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.

  • Wellington Management Group held 194,108 shares of Artiva Biotherapeutics worth $1.88M as of Q2 2026.
  • Wellington Management Group left its Artiva Biotherapeutics share count unchanged in Q2 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1641 holding.
  • Wellington Management Group first reported a position in Artiva Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • Wellington Management Group's Artiva Biotherapeutics position peaked at $2.91M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.